Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124

NCT03087968 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No longer a sub-study - Changing to an independent parallel study

Conditions

Severe Alcoholic Hepatitis

Interventions

DRUG: GS-4997
DRUG: Prednisolone
DEVICE: HepQuant SHUNT Test
DRUG: Placebo

Sponsor

HepQuant, LLC